News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
24,131 Results
Type
Article (1422)
Company Profile (13)
Press Release (22692)
Multimedia
Podcasts (43)
Webinars (14)
Section
Business (5647)
Career Advice (37)
Deals (706)
Drug Delivery (25)
Drug Development (1387)
Employer Resources (14)
FDA (349)
Job Trends (484)
News (7332)
Policy (452)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (2)
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
40 Under 40 (2)
Academia (142)
Accelerated approval (5)
ADA (4)
Adcomms (1)
Allergies (10)
Alliances (2244)
ALS (28)
Alzheimer's disease (184)
Antibody-drug conjugate (ADC) (60)
Approvals (389)
Artificial intelligence (1080)
ASCO (29)
Autoimmune disease (56)
Automation (29)
Bankruptcy (7)
Belgium (3)
Best Places to Work (438)
BIO (12)
Biologics (9)
BIOSECURE Act (4)
Biosimilars (9)
BioSpace Insights (77)
Biotechnology (11)
Bispecific (8)
Bladder cancer (19)
Brain cancer (11)
Breast cancer (148)
Cancer (973)
Cardiovascular disease (81)
Career advice (48)
Career pathing (8)
CAR-T (30)
CDC (2)
CDMO (31)
Cell therapy (86)
Cervical cancer (13)
Clinical research (1481)
Collaboration (750)
Commercialization (16)
Compensation (28)
Complete response letters (5)
COVID-19 (105)
CRISPR (22)
CRO (3)
C-suite (216)
Cystic fibrosis (12)
Data (874)
Decentralized trials (1)
Denatured (26)
Depression (13)
Dermatology (13)
Diabetes (67)
Diagnostics (969)
Digital health (46)
Diversity (2)
Diversity, equity & inclusion (2)
Drug discovery (276)
Drug pricing (6)
Drug shortages (2)
Duchenne muscular dystrophy (5)
Earnings (1996)
Editorial (3)
Employer branding (1)
Employer resources (14)
ESMO (46)
Events (3742)
Executive appointments (152)
Eye disease (3)
FDA (822)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (425)
Gene editing (38)
Generative AI (106)
Gene therapy (63)
GLP-1 (76)
Government (118)
Guidances (50)
Healthcare (926)
Hematology (12)
HIV (7)
Huntington's disease (3)
IgA nephropathy (1)
Immunology and inflammation (38)
Immuno-oncology (16)
Indications (32)
Infectious disease (143)
Inflammatory bowel disease (30)
Inflation Reduction Act (1)
Influenza (7)
Intellectual property (28)
Interviews (11)
IPO (364)
IRA (2)
Job creations (31)
Job search strategy (19)
JPM (12)
Kidney cancer (1)
Kidney disease (9)
Labor market (27)
Layoffs (25)
Leadership (6)
Legal (35)
Licensing (16)
Liver cancer (17)
Longevity (18)
Lung cancer (150)
Lung diease (2)
Lymphoma (32)
Machine learning (64)
Management (8)
Manufacturing (152)
MASH (35)
Medical device (588)
Medtech (652)
Melanoma (25)
Mergers & acquisitions (528)
Metabolic disorders (174)
mRNA (48)
Multiple sclerosis (15)
Multispecific (1)
Netherlands (10)
Neurodegenerative disease (52)
Neuropsychiatric disorders (7)
Neuroscience (399)
Neurotech (2)
NextGen: Class of 2026 (184)
Non-profit (173)
Now hiring (17)
Obesity (66)
Opinion (47)
Ovarian cancer (12)
Pain (18)
Pancreatic cancer (26)
Parkinson's disease (52)
Partnered (13)
Patents (67)
Patient advocacy (1)
Patient recruitment (86)
Patient selection (11)
Peanut (3)
People (2073)
Peptides (5)
Pharmaceutical (1)
Pharmacy benefit managers (1)
Phase 1 (526)
Phase 2 (705)
Phase 3 (394)
Pipeline (1530)
Policy (41)
Postmarket research (26)
Preclinical (296)
Press Release (2)
Prostate cancer (63)
Psychedelics (5)
Radiopharmaceuticals (27)
Rare diseases (104)
Real estate (84)
Recruiting (8)
Regenerative medicine (1)
Regulatory (849)
Reports (14)
Research institute (143)
Resumes & cover letters (12)
Rett syndrome (5)
RNA editing (9)
RSV (3)
Schizophrenia (33)
Series A (74)
Series B (49)
Series C (1)
Sickle cell disease (6)
Special edition (4)
Sponsored (8)
Startups (171)
Stem cells (1)
Substance use disorders (1)
Supply chain (22)
Switzerland (1)
Tariffs (5)
The Weekly (17)
Vaccines (108)
Venture capital (48)
Weight loss (31)
Wet AMD (3)
Women's health (22)
Worklife (1)
Date
Today (13)
Last 7 days (104)
Last 30 days (448)
Last 365 days (3979)
2026 (3689)
2025 (3094)
2024 (2920)
2023 (2453)
2022 (2692)
2021 (2519)
2020 (2083)
2019 (1902)
2018 (975)
2017 (457)
2016 (229)
2015 (211)
2014 (87)
2013 (60)
2012 (79)
2011 (130)
2010 (106)
Location
Africa (14)
Alabama (6)
Alaska (1)
Arizona (42)
Arkansas (3)
Asia (2129)
Australia (102)
California (1697)
Canada (421)
China (240)
Colorado (80)
Connecticut (101)
Delaware (79)
Europe (3584)
Florida (188)
Georgia (17)
Hawaii (1)
Idaho (2)
Illinois (216)
India (9)
Indiana (60)
Iowa (3)
Japan (74)
Kansas (4)
Kentucky (7)
Louisiana (13)
Maine (4)
Maryland (280)
Massachusetts (1189)
Michigan (32)
Minnesota (59)
Mississippi (1)
Missouri (14)
Montana (3)
Nebraska (2)
Nevada (26)
New Hampshire (25)
New Jersey (264)
New Mexico (13)
New York (409)
North Carolina (192)
Northern California (1002)
Ohio (46)
Oklahoma (3)
Oregon (6)
Pennsylvania (153)
Puerto Rico (4)
Rhode Island (3)
South America (23)
South Carolina (8)
Southern California (519)
Tennessee (19)
Texas (488)
United States (5687)
Utah (83)
Vermont (1)
Virginia (43)
Washington D.C. (9)
Washington State (109)
Wisconsin (18)
24,131 Results for "zephyr ai".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zephyr AI Announces AACR Schedule of Presentations
April 15, 2026
·
2 min read
Press Releases
Zephyr AI Appoints Dr. Lisa Eli as Chief Scientific Officer
April 21, 2026
·
2 min read
Press Releases
iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products
New Agentic AI tools for protein discovery and disease trend prediction take iSpecimen beyond its biospecimen marketplace
November 5, 2026
·
6 min read
Press Releases
Thunk.AI Publishes Open Benchmark for AI Automation in Pharmacovigilance Case Intake, Demonstrates 99%+ AI Reliability
Benchmark of 75 adverse-event reports measures how accurately AI agents triage cases and identify expedited regulatory reports under a written SOP
October 8, 2026
·
1 min read
Press Releases
Segal Trials Reinforces Leadership in Acute Schizophrenia Research Following Participation in MapLight Therapeutics’ Phase 2 ZEPHYR Study
August 23, 2026
·
3 min read
Job Trends
The human cost of AI interviews
While artificial intelligence can help biotech and pharma companies more quickly vet job applicants, it can also turn off the very people they want to employ. Two recruiting experts discuss AI’s role and limitations in the hiring process.
September 24, 2026
·
6 min read
·
Angela Gabriel
Manufacturing
Compliance concerns hinder rollout of AI in drug manufacturing: Survey
While AI is taking off in biopharma for administrative tasks and drug discovery efforts, more than 90% of drugmakers have yet to commit to scaling AI use in regulated biopharma manufacturing, according to CRB’s new Horizons: Life Sciences report.
October 6, 2026
·
2 min read
·
Nick Paul Taylor
China
In China’s shadow, Pfizer CEO calls for AI savings to bolster Big Pharma
Speaking at the Jefferies conference in London, Pfizer CEO Albert Bourla warned of China’s rise and spoke to how companies like his can compete by leveraging AI-discovered savings.
November 18, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Biointron Introduces RushDATA™ to Accelerate Wet-Lab Validation for AI-Driven Antibody Discovery
· 1-day CHO expression and rapid characterization help close the gap between computational design and experimental validation · 20,000+ molecules per week capacity supports large-scale screening of AI-generated antibody candidates · Integrated binding and developability assessments generate standardized, multidimensional datasets for candidate selection and AI/ML workflows
October 23, 2026
·
1 min read
Press Releases
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
July 27, 2026
·
11 min read
1 of 2,414
Next